about
The potential of anti-malarial compounds derived from African medicinal plants, part II: a pharmacological evaluation of non-alkaloids and non-terpenoidsAfroDb: a select highly potent and diverse natural product library from African medicinal plantsNew antimalarial hits from Dacryodes edulis (Burseraceae)--part I: isolation, in vitro activity, in silico "drug-likeness" and pharmacokinetic profilesVirtualizing the p-ANAPL library: a step towards drug discovery from African medicinal plants11th German Conference on Chemoinformatics (GCC 2015) : Fulda, Germany. 8-10 November 2015.Pharmacophore modeling and in silico toxicity assessment of potential anticancer agents from African medicinal plants4-aroylpiperidines and 4-(α-hydroxyphenyl)piperidines as selective sigma-1 receptor ligands: synthesis, preliminary pharmacological evaluation and computational studiesThe potential of anti-malarial compounds derived from African medicinal plants, part III: an in silico evaluation of drug metabolism and pharmacokinetics profiling.Protease-inhibiting, molecular modeling and antimicrobial activities of extracts and constituents from Helichrysum foetidum and Helichrysum mechowianum (compositae)CamMedNP: building the Cameroonian 3D structural natural products database for virtual screening.In silico drug metabolism and pharmacokinetic profiles of natural products from medicinal plants in the Congo basin.Control of malaria and other vector-borne protozoan diseases in the tropics: enduring challenges despite considerable progress and achievements.Antiparasitic Sesquiterpenes from the Cameroonian Spice Scleria striatinux and Preliminary In Vitro and In Silico DMPK Assessment.Anti-onchocerca Metabolites from Cyperus articulatus: Isolation, In Vitro Activity and In Silico 'Drug-Likeness'.Cameroonian medicinal plants: a bioactivity versus ethnobotanical survey and chemotaxonomic classificationScreening of the Pan-African natural product library identifies ixoratannin A-2 and boldine as novel HIV-1 inhibitors.Virtually Designed Triclosan-Based Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis and of Plasmodium falciparum.The potential of anti-malarial compounds derived from African medicinal plants, part I: a pharmacological evaluation of alkaloids and terpenoids.A bioactivity versus ethnobotanical survey of medicinal plants from Nigeria, west Africa.Bioactive natural products derived from the Central African flora against neglected tropical diseases and HIV.Perspectives on tuberculosis pathogenesis and discovery of anti- tubercular drugs.Exploring Cancer Therapeutics with Natural Products from African Medicinal Plants, Part I: Xanthones, Quinones, Steroids, Coumarins, Phenolics and other Classes of Compounds.Anti-trypanosomal activity of nigerian plants and their constituents.NANPDB: A Resource for Natural Products from Northern African Sources.Targeting cysteine proteases from Plasmodium falciparum: A general overview, rational drug design and computational approaches for drug discovery.In silico toxicity profiling of natural product compound libraries from African flora with anti-malarial and anti-HIV properties.Molecular modeling of potential anticancer agents from African medicinal plants.Identification of Bichalcones as Sirtuin Inhibitors by Virtual Screening and In Vitro Testing.Compounds from African Medicinal Plants with Activities Against Selected Parasitic Diseases: Schistosomiasis, Trypanosomiasis and Leishmaniasis.Antitumour, acute toxicity and molecular modeling studies of 4-(pyridin-4-yl)-6-(thiophen-2-yl) pyrimidin-2(1H)-one against Ehrlich ascites carcinoma and sarcoma-180.Structurally simple synthetic 1, 4-disubstituted piperidines with high selectivity for resistant Plasmodium falciparum1-Aryl-1,2,3,4-tetrahydroisoquinolines as potential antimalarials: synthesis, in vitro antiplasmodial activity and in silico pharmacokinetics evaluationIdentification of Bichalcones as Sirtuin Inhibitors by Virtual Screening and in Vitro TestingThe chemistry and bioactivity of Southern African flora II: flavonoids, quinones and minor compound classesBinding of pyrazole-based inhibitors to Mycobacterium tuberculosis pantothenate synthetase: docking and MM-GB(PB)SA analysisConMedNP: a natural product library from Central African medicinal plants for drug discoveryHow “drug-like” are naturally occurring anti-cancer compounds?The uniqueness and therapeutic value of natural products from West African medicinal plants, part II: terpenoids, geographical distribution and drug discoveryThe uniqueness and therapeutic value of natural products from West African medicinal plants, part III: least abundant compound classesThe uniqueness and therapeutic value of natural products from West African medicinal plants. Part I: uniqueness and chemotaxonomy
P50
Q26824879-6863CBE2-1D10-4781-8B65-C3901363F485Q28534724-844B7B3B-F9AD-4D5B-A019-88F757058382Q28535324-A0D0BC0F-FAB2-42ED-9344-4D05F13D19A9Q28540495-D0FC095B-9464-4588-A3EC-B5B779B13C08Q28550032-B08ED866-B35D-467E-A051-17106D8926CAQ28596537-824C158E-90D0-4064-A016-CC2060F8DF6FQ28829344-688E0720-1362-4BC9-AB39-B601C347D489Q30315979-65DDEB35-0399-45A3-8FE6-D77C833F3315Q30316483-6C6D5DF8-B734-4EA8-B43C-A0DF354BD8BFQ30317837-A874A07E-B34B-45FA-B079-809B2090BB42Q30317914-E2B81090-71BF-4FDE-B9C8-029E9BBA5326Q30565638-FF949517-0A7B-4FFE-9C18-6573052A0F4CQ33825850-AD5053C9-C463-4234-8EC0-E582F5421DE4Q33953660-E53DADAF-2428-4C8A-A64C-3FCBE51A7706Q34784811-845591EF-4F71-4F23-9FEC-14D14D1A7E76Q35591789-71A26CC7-3ECE-4C09-8AF2-574052179E33Q36094825-70FADFF6-112D-4C54-93AA-13B1AB63817DQ37427043-E4811C59-20D5-48B5-8193-9D68D98E22E4Q37642180-C9672576-B7EE-4ECC-AFC0-593398D8DEB2Q38118605-A84124D7-08C8-4CFF-832D-788FD19BA1CEQ38227407-72F0BE09-7A1C-4333-A604-586FC7EE3AFDQ38316719-453838B0-8FB8-42B7-A451-8956CAFBF84CQ38451299-EA1FA1AB-043E-4FBB-839A-1168D4D17AD2Q38713775-95A95214-87FA-4738-8385-2770B4C22166Q39047339-09BC1921-7393-44F0-B89C-ED7968AE1F09Q47250374-46F3EA3A-8DB6-435E-956D-35815F66BF88Q47615282-92A25285-FF4E-4C80-A230-ACC453F8D534Q50002130-B99CA281-DDE5-4023-B8A7-6633DAF04492Q55000698-D6FC38BC-26EB-4689-A9A9-29CE626258D5Q55609093-230EC9EC-BF6F-439F-B116-212888D3A132Q56366132-12D84BEE-2B6A-4ADD-826B-F23701D68EF6Q58848367-16D28B26-658E-4160-A498-212516EC4ED5Q58860035-77112DDB-D17F-4206-9275-7E90C0896147Q58860050-4957FE35-8990-4DC6-B08A-46C272DF941FQ58860051-33268E58-D579-4DE6-A301-E060657EA70CQ58860055-B3FD73BB-FAD6-4E7B-9C90-9568D9FE9C5CQ58860057-0E2240D2-EFE1-490F-8675-6619FEF73478Q58860062-B6B5CA33-64D0-4488-A10F-0FA78150BA71Q58860064-3100482D-B6E8-48EE-899D-B99BD0D247DBQ58860065-19FF2FDD-D727-4F54-A3EA-35F863D0B735
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Fidele Ntie-Kang
@ast
Fidele Ntie-Kang
@en
Fidele Ntie-Kang
@es
Fidele Ntie-Kang
@nl
Fidele Ntie-Kang
@sl
type
label
Fidele Ntie-Kang
@ast
Fidele Ntie-Kang
@en
Fidele Ntie-Kang
@es
Fidele Ntie-Kang
@nl
Fidele Ntie-Kang
@sl
altLabel
Fidele Ntie Kang
@en
prefLabel
Fidele Ntie-Kang
@ast
Fidele Ntie-Kang
@en
Fidele Ntie-Kang
@es
Fidele Ntie-Kang
@nl
Fidele Ntie-Kang
@sl
P106
P1153
55649436300
P21
P2798
P31
P496
0000-0003-0795-394X